The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo(University of Bristol), Caroline M. Tanner(University of California, San Francisco), Sirwan K.L. Darweesh(Radboud University Nijmegen), Marta San Luciano(University of California, San Francisco), Connie Marras(University of Toronto), Jorge J. Llibre‐Guerra(Washington University in St. Louis)
Cited by 809
Related Papers
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Common variants in the GDF5-UQCC region are associated with variation in human height
|Nature Genetics|2008|401
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|390